Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1987 Jan;40(1):19–25. doi: 10.1136/jcp.40.1.19

Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.

A K Ghosh, K C Gatter, M S Dunnill, D Y Mason
PMCID: PMC1140823  PMID: 2434531

Abstract

A panel of seven monoclonal antiepithelial antibodies of different specificities, including anticytokeratin, human milk fat globule membrane, C, and carcinoembryonic antigen (CEA) were used with the alkaline phosphatase-antialkaline phosphatase (APAAP) immunostaining technique to determine their value in the differentiation between benign and malignant mesothelial cells and lung carcinoma in histological preparations. The anticytokeratin antibody reacted strongly with all cases of reactive mesothelium, mesothelioma, and lung carcinoma. Antibodies to human milk fat globule membrane and the Ca antigen stained mesothelioma and carcinoma and 43% of cases of reactive mesothelium. Staining for carcinoembryonic antigen was not detected in reactive mesothelium or mesothelioma, but was present in most of the lung carcinomas. CEA seemed to be the single most useful marker in distinguishing carcinoma from mesothelioma in that a positive reaction for CEA would indicate carcinoma rather than mesothelioma.

Full text

PDF
20

Images in this article

21Fig 1a
on p.21
21Fig 1b
on p.21
21Fig 1c
on p.21
21Fig 2
on p.21
22Fig 3
on p.22
22Fig 4
on p.22

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashall F., Bramwell M. E., Harris H. A new marker for human cancer cells. 1 The Ca antigen and the Ca1 antibody. Lancet. 1982 Jul 3;2(8288):1–6. doi: 10.1016/s0140-6736(82)91150-3. [DOI] [PubMed] [Google Scholar]
  2. Bramwell M. E., Ghosh A. K., Smith W. D., Wiseman G., Spriggs A. I., Harris H. Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions. Cancer. 1985 Jul 1;56(1):105–110. doi: 10.1002/1097-0142(19850701)56:1<105::aid-cncr2820560117>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  3. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  4. Cordell J., Richardson T. C., Pulford K. A., Ghosh A. K., Gatter K. C., Heyderman E., Mason D. Y. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer. 1985 Sep;52(3):347–354. doi: 10.1038/bjc.1985.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Corson J. M., Pinkus G. S. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol. 1982 Jul;108(1):80–88. [PMC free article] [PubMed] [Google Scholar]
  6. Epenetos A. A., Canti G., Taylor-Papadimitriou J., Curling M., Bodmer W. F. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet. 1982 Nov 6;2(8306):1004–1006. doi: 10.1016/s0140-6736(82)90047-2. [DOI] [PubMed] [Google Scholar]
  7. Gatter K. C., Abdulaziz Z., Beverley P., Corvalan J. R., Ford C., Lane E. B., Mota M., Nash J. R., Pulford K., Stein H. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol. 1982 Nov;35(11):1253–1267. doi: 10.1136/jcp.35.11.1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gatter K. C., Dunnill M. S., Pulford K. A., Heryet A., Mason D. Y. Human lung tumours: a correlation of antigenic profile with histological type. Histopathology. 1985 Aug;9(8):805–823. doi: 10.1111/j.1365-2559.1985.tb02868.x. [DOI] [PubMed] [Google Scholar]
  9. Ghosh A. K., Spriggs A. I., Curling M. Tumour markers in serous effusions. Lancet. 1984 Feb 11;1(8372):338–338. doi: 10.1016/s0140-6736(84)90381-7. [DOI] [PubMed] [Google Scholar]
  10. Ghosh A. K., Spriggs A. I., Taylor-Papadimitriou J., Mason D. Y. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. J Clin Pathol. 1983 Oct;36(10):1154–1164. doi: 10.1136/jcp.36.10.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gusterson B., Mitchell D., Warburton M., Sloane J. Immunohistochemical localisation of keratin in human lung tumours. Virchows Arch A Pathol Anat Histol. 1982;394(3):269–277. doi: 10.1007/BF00430670. [DOI] [PubMed] [Google Scholar]
  12. Holden J., Churg A. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol. 1984 Apr;8(4):277–279. doi: 10.1097/00000478-198404000-00004. [DOI] [PubMed] [Google Scholar]
  13. Kahn H. J., Hanna W., Yeger H., Baumal R. Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy. Am J Pathol. 1982 Nov;109(2):206–214. [PMC free article] [PubMed] [Google Scholar]
  14. Kwee W. S., Veldhuizen R. W., Golding R. P., Mullink H., Stam J., Donner R., Boon M. E. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining. Virchows Arch A Pathol Anat Histol. 1982;397(3):287–299. doi: 10.1007/BF00496570. [DOI] [PubMed] [Google Scholar]
  15. Loosli H., Hurlimann J. Immunohistological study of malignant diffuse mesotheliomas of the pleura. Histopathology. 1984 Sep;8(5):793–803. doi: 10.1111/j.1365-2559.1984.tb02395.x. [DOI] [PubMed] [Google Scholar]
  16. Marshall R. J., Herbert A., Braye S. G., Jones D. B. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium. J Clin Pathol. 1984 Nov;37(11):1215–1221. doi: 10.1136/jcp.37.11.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McCaughey W. T. Asbestos and neoplasia: diffuse mesothelial tumors. Criteria for diagnosis of diffuse mesothelial tumors. Ann N Y Acad Sci. 1965 Dec 31;132(1):603–613. doi: 10.1111/j.1749-6632.1965.tb41140.x. [DOI] [PubMed] [Google Scholar]
  18. Said J. W., Nash G., Banks-Schlegel S., Sassoon A. F., Murakami S., Shintaku I. P. Keratin in human lung tumors. Patterns of localization of different-molecular-weight keratin proteins. Am J Pathol. 1983 Oct;113(1):27–32. [PMC free article] [PubMed] [Google Scholar]
  19. Said J. W., Nash G., Tepper G., Banks-Schlegel S. Keratin proteins and carcinoembryonic antigen in lung carcinoma: an immunoperoxidase study of fifty-four cases, with ultrastructural correlations. Hum Pathol. 1983 Jan;14(1):70–76. doi: 10.1016/s0046-8177(83)80048-3. [DOI] [PubMed] [Google Scholar]
  20. Taylor-Papadimitriou J., Peterson J. A., Arklie J., Burchell J., Ceriani R. L., Bodmer W. F. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer. 1981 Jul 15;28(1):17–21. doi: 10.1002/ijc.2910280104. [DOI] [PubMed] [Google Scholar]
  21. Viac J., Reano A., Brochier J., Staquet M. J., Thivolet J. Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol. 1983 Oct;81(4):351–354. doi: 10.1111/1523-1747.ep12519941. [DOI] [PubMed] [Google Scholar]
  22. Wang N. S., Huang S. N., Gold P. Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer. 1979 Sep;44(3):937–943. doi: 10.1002/1097-0142(197909)44:3<937::aid-cncr2820440322>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES